Company
Headquarters: Miami Beach, FL, United States
Employees: 346
CEO: Mr. Todd Magazine
| Company | Market Cap (USD) |
|---|---|
| Lilly | $689.42 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $487.54 B |
| Johnson & Johnson | $353.05 B |
| AbbVie | $301.60 B |
AirSculpt Technologies, Inc., together with its subsidiaries, focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States. The company offers AirSculpt, a next-generation body contouring procedure that removes unwanted fat and tightens skin in a minimally invasive procedure. It also provides AirSculpt+, a procedure that permanently removes fat and tightens the skin with unparalleled precision and finesse; and AirSculpt Smooth, an advanced cellulite removal tool. In addition, it provides fat removal procedures across treatment areas, such as the stomach, back, and buttocks; and fat transfer procedures that use the patient's own fat cells to enhance the breasts, buttocks, hips, or other areas. The company's body contouring procedures also include the Power BBL, a Brazilian butt lift procedure; the Up a Cup, a breast enhancement procedure; and the Hip Flip, an hourglass contouring procedure. It operates various centers. The company was founded in 2012 and is headquartered in Miami Beach, Florida.
| Last Financial Reports Date | Dec. 31, 2023 |
| Revenue TTM | $195.9 M |
| EBITDA | $19.5 M |
| Gross Profit TTM | $121.9 M |
| Profit Margin | -2.29% |
| Operating Margin | 2.92% |
| Quarterly Revenue Growth | 17.00% |
AirSculpt Technologies, Inc. has the following listings and related stock indices.
Stock: NASDAQ: AIRS wb_incandescent